METHOD AND COMPOSITION FOR CURING PATIENT OF METABOLIC FAILRE HEPATOPATHY

摘要

PURPOSE: To obtain the subject composition containing thymosin (Tα1 ) in an amount for reducing hepatitis B viruses, capable of being administered into a hepatitis B-infected patient of hepatic decompensation disease to negative a serum reaction on hepatitis B virus DNA, and adaptable to the transplantation of livers. CONSTITUTION: This composition comprises a pharmaceutical administration unit (preferably 1.6 mg) containing Tα1 in an amount for reducing hepatitis B viruses. The administration unit is preferably injected into a hepatitis B- infected patient of hepatic decompensation disease to negative a serum reaction on hepatitis B virus DNA.